NCT05988658View on ClinicalTrials.gov

Combining Biomarkers and Electronic Risk Scores to Predict AKI in Hospitalized Patients

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

January 5, 2024

Primary Completion Date

March 1, 2027

Study Completion Date

March 1, 2028

Conditions
Acute Kidney InjuryBiomarkers
Interventions
DEVICE

ESTOP - AKI 2.0

Medical software as a Noninvasive medical device, which at the time of the project will not implement directly into subject/clinical care.

Trial Locations (2)

53792

RECRUITING

University of Wisconsin Hospital, Madison

60637

RECRUITING

University of Chicago Medical Center, Chicago

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

University of Wisconsin, Madison

OTHER

lead

University of Chicago

OTHER